Latest Health News

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Field Solutions Holdings reports a neutral operating cashflow for Q2 2024, while navigating a trading halt and preparing for a capital raise alongside key business divestments.

Skin Elements Limited reports steady progress in commercialising its plant-based SE Formula biotechnology, highlighted by ongoing product trials, a successful R&D rebate, and a $513k non-renounceable entitlement issue.

Environmental Clean Technologies Limited has formed a joint venture and launched field trials for its innovative COLDry lignite-nitrogen fertiliser, marking a pivotal step toward commercialisation and revenue generation.

Micro-X announces a strategic pivot towards medical imaging, anchored by a $25 million US government contract to develop a portable Full Body CT scanner, while discontinuing its Argus security operations to streamline costs.

Advanced Health Intelligence Ltd (AHI) has secured USD 4 million in convertible debt funding and launched two new commercial partnerships in Canada and the UK, marking significant progress despite its ongoing ASX trading suspension.

Eneco Refresh Limited reported a robust 9% revenue increase in Q2 2024, fueled by strong demand in its Refresh Waters segment and strategic operational changes in Refresh Plastics. Despite rising logistics costs, the company improved profitability and maintained a solid cash position.

Cardiex has kicked off deliveries of its CONNEQT Pulse arterial health monitors in the U.S., reporting strong preorder momentum and a 150% sales increase in December. The company’s strategic operational shifts and pharma partnerships set the stage for sustained growth in 2025.

LawFinance Limited has completed a significant debt restructuring, easing financial pressures, but faces ongoing challenges with declining cash collections and uncertain progress on its Trident Health Group initiative.

Cardiex Limited reported a $2.94 million cash outflow for Q2 FY2025 but bolstered its balance sheet with a $3.25 million placement. The company has begun delivering its CONNEQT Pulse units, signaling a new revenue stream and ongoing R&D investment.

DGR Global Limited's December 2024 quarterly report reveals active exploration progress, ongoing legal disputes over Armour Energy, and strategic financing initiatives aimed at sustaining growth.

Ten Sixty Four Limited’s latest quarterly report reveals a notable decline in gold output and cash reserves, alongside steady progress on key projects and a pivotal restructuring agreement.